Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | E42X5 | — |
The vaccine was administer on 24-Mar-2025, and the vaccine was expire since 15-Mar-2025; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 22-year-old male patient who received HBV (Engerix B) (batch number E42X5, expiry date 15-MAR-2025) for prophylaxis. On 24-MAR-2025, the patient received Engerix B. On 24-MAR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: The vaccine was administer on 24-Mar-2025, and the vaccine was expire since 15-Mar-2025). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-MAR-2025 The reporter was informed by a nurse that a vaccine (Engerix-B) was expired and was given to a patient, which led to expired vaccine used. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up.